Navigation Links
Indian Introduces Paan-flavoured Condoms

A condom flavoured with the popular mixture of betel nut and tobacco known as paan is to go on sale in India, newspapers said Tuesday .

State-owned company Hindustan Latex has already tested the pungent and bitter mixture on their main market, sex workers, who preferred it to other flavours such as banana and chocolate, the Hindustan Times reported

"The community loved it as most of the sex workers chew paan," Sanjeev Gaikwad, a director at advocacy group Family Health International who helped launch the new condom as part of HIV-AIDS prevention efforts, told the newspaper.

Varieties of betel nut, tobacco and often sweet and bitter pastes are mixed in a concotion called paan sold at street-side stalls across South Asia.

Aficionados chew the mixture wrapped in a leaf and then spit the red saliva onto the sidewalks or buildings that are adorned with the tell-tale stains.

The condoms will be sold to the public later this year, but sex workers will be given supplies immediately, the newspaper said.

India said earlier this month that the number of its people living with HIV-AIDS stands at two million to 3.1 million, sharply lower than earlier estimates, but vowed to spend billions to check a wider epidemic.

Previous estimates from India's National AIDS Control Organisation (NACO) had put the HIV caseload at 5.2 million, while UNAIDS in 2006 estimated 5.7 million cases which would have been the highest in the world.


'"/>




Page: 1

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
(Date:7/3/2009)...reform details emerge, more entrepreneurs are wond...business insurance premiums. Now, they are getting...the Small Business Health Insurance Network to fin...s, Minn. (PRWEB) July 3, 2009 -- The health care r...h has entrepreneurs worried about how this will af...
(Date:7/2/2009)...wswire/ -- Acetaminophen is an ingredient found in...to help relieve pain and reduce fever. Many peopl...and prescription brand names, Vicodin and Percocet... June 30, 2009 to address liver related injuries d...ed 20-17 to urge the FDA to put a ban on Vicodin a...
(Date:7/2/2009)...re/ -- A new analysis of the incidence of breast c...of 0 to 84 from 2000 to 2005 shows a 72 percent sp...y of Health, with the sharpest uptick of +28.6 per...to 44). , , The new results, which rely on hosp...eries rather than official estimations computed us...
(Date:7/2/2009)...is B virus (HBV) are associated with the developme...ents with HBV infections are at increased risk of ... the Journal of the National Cancer Institute , p...wn cause of hepatocellular carcinoma (HCC), the mo...ave looked at whether patients with specific mutat...
Breaking Medicine News(10 mins):Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 2Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 3
...ion is planning to approve the first home based ra...l be available within 20 minutes of the test witho...Quick test kit is now available only to doctors an.... This is a strip test, in which a single control ...
...ause for hospitalization of patients with diabetes...equent amputation. Ischemia, neuropathy, and infec...tissue necrosis and ulcers//. Diabetic foot infect...re. Early recognition of lesions and prompt initia...
... idiopathic inflammatory disorder of the gastroint...completely understood, many experimental and clini...estinal microflora in its pathogenesis//. In gene... damage can result from failure of normal regulato...
...s the National Dental Hygiene Month (NDHM) and the...s announced that it would be focusing on the relat...sease during this whole time//. Using tobacco or t...risk factor in the development of oral cancer. Smo...
Other Medicine News:Health News:Home Based Rapid HIV Test Kit to be approved by US – OraQuick Test Ki 2Health News:The Polymicrobial Nature Of Diabetic Foot Infections 2Health News:Bifidogenic Growth Stimulator: A Non-Toxic Way To Treat Ulcerative Colitis 2
(Date:7/2/2009)...y 3 ,ThromboGenics NV (E...,BioInvent International (OMXS: BINV) announce tha...t of patients for their Phase II trial of,TB-402....st cohort of 100,patients ahead of schedule. TB-4...being developed for the prevention of deep vein th...
(Date:7/1/2009)...e-FirstCall/ -- The largest study of,the genetics...eral new common,single-letter variants in the seq...f the disease. The study, by a multinational conso...etics (Nasdaq: DCGN ), analyzed the genomes of,m...from fourteen countries.,It is published today in...
(Date:6/30/2009)...In two recent COPD studies sponsored by DEY LP, PA...ra and Ultra II) were used to show that nebulized ...c.) improves pulmonary function. , , "We are p... exclusive nebulizer systems for recent studies co...nd et al. used an open-label crossover design allo...
(Date:6/30/2009)... Therapeutics Inc. today announced the initiation ... with complicated urinary tract infections. CXA-1...in antibiotic with excellent in vitro and in vi...luding drug resistant isolates. Calixa is investi...s bacterial infections in hospitalized patients. ,...
Breaking Medicine Technology:ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 3ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 4ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 5deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 4deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 5PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 2Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2WuXi PharmaTech to Acquire AppTec Laboratory Services Inc 2443 1WuXi PharmaTech to Acquire AppTec Laboratory Services Inc 2443 2WuXi PharmaTech to Acquire AppTec Laboratory Services Inc 2443 3WuXi PharmaTech to Acquire AppTec Laboratory Services Inc 2443 4WuXi PharmaTech to Acquire AppTec Laboratory Services Inc 2443 5Pharmos Corporation Announces Board and Management Changes 2440 1Pharmos Corporation Announces Board and Management Changes 2440 2Pharmos Corporation Announces Board and Management Changes 2440 3Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection 1135 1Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection 1135 2Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection 1135 3Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection 1135 4Novel Mechanism for Long Term Learning Identified by Carnegie Mellon Researchers 1133 1Novel Mechanism for Long Term Learning Identified by Carnegie Mellon Researchers 1133 2Novel Mechanism for Long Term Learning Identified by Carnegie Mellon Researchers 1133 3
...wswire/ -- , - Cipralex Better Tolerated and at Le...eck A/S announces new study data published today i..., demonstrating that,Cipralex(R) (escitalopram) wa... patients with major depressive disorder (MDD) and...t(1). The study,directly compared Cipralex(R) (an ...
...CSE: GEN) announced,today pre-clinical data illust...mab) antibody may have broad potential,to treat ca...dermal,growth factor receptor). , Recently, mutati... EGFr have been identified in tumors from lung can...tor in the potential success of,EGFr-directed trea...
Other Medicine Technology:Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 2Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 3Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 4Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 5
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: